Unavailable
Unavailable
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/30/2021 | $20.00 | Outperform | Northland Capital Markets |
Comprehensive "clinic-on-the-wrist" integration combining hardware, application firmware, and cloud analytics will accelerate deployment for customers and partners. Rockley Photonics, a leading global silicon photonics technology company, today revealed its complete full-stack, "clinic-on-the-wrist" digital health sensor system. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210714005499/en/Wristband to be used in human studies (Photo: Business Wire) Rockley's sensor module and associated reference designs for consumer products integrate hardware and application firmware to enable wearable devices to monitor multiple biomarkers,
OXFORD, United Kingdom & PASADENA, Calif.--(BUSINESS WIRE)--Rockley Photonics, Ltd. (“the Company” or “Rockley”), a leading global supplier of integrated silicon photonic chips and modules across multiple markets, today announced that it has entered into a definitive agreement to combine with SC Health Corp. (“SC Health”) (NYSE: SCPE), a publicly traded special purpose acquisition company. The transaction will result in Rockley becoming a publicly traded company on the NYSE under the symbol RKLY and values the Company at a pro forma enterprise value of $1.2 billion. Transforming healthcare through revolutionary “clinic-on-the-wrist” monitoring technology The transaction will accel
SINGAPORE--(BUSINESS WIRE)--SC Health Corp. (NYSE: SCPE) (the “Company”) announced today it has entered into a non-binding letter of intent (the “Letter of Intent”) with a next generation technology developer (the “Target”) for an initial business combination. The Target has developed a unique technology targeting consumer healthcare applications that delivers market-leading performance and accuracy. The Target is led by a world class management team with significant experience in leading innovative, high-growth companies in the sector. SC Health’s management team believes the Target is a compelling investment opportunity given its cutting-edge technology and commercial opportunity
4 - SC Health Corp (0001764301) (Issuer)
4 - SC Health Corp (0001764301) (Issuer)
4 - SC Health Corp (0001764301) (Issuer)
15-12B - SC Health Corp (0001764301) (Filer)
8-K - SC Health Corp (0001764301) (Filer)
25-NSE - SC Health Corp (0001764301) (Subject)
SC 13G/A - SC Health Corp (0001764301) (Subject)
SC 13G - SC Health Corp (0001764301) (Subject)
SC 13G - SC Health Corp (0001764301) (Subject)
Northland Capital Markets initiated coverage of SC Health with a rating of Outperform and set a new price target of $20.00